Opioid Analgesics: A friend or a foe?

Introduction

Opioid analgesics are the type of analgesics (pain-relieving medicines) that work mainly in the central nervous system (CNS) by acting on μ (mu) receptors. Instead of just reducing pain at the site of injury, they block the transmission of pain signals to the brain.

In simple terms, these drugs don’t just reduce pain — they also change how your brain perceives and reacts to it, making the pain feel less intense and more manageable.

However, there is an important concern. Opioid analgesics can be habit-forming, especially when used for a long time. With repeated use, the body may develop:

• Dependence (needing the drug to function normally)
• Tolerance (requiring higher doses for the same effect)

Based on their strength and activity, opioids are commonly classified into:

• Strong opioids (e.g., morphine, fentanyl)
• Weak opioids (e.g., tramadol, codeine)
• Partial agonists (e.g., buprenorphine)

While these medicines are highly effective in relieving moderate to severe pain, they should always be used carefully and under medical supervision to avoid misuse and potential risks.

Examples:

Some of the Opioid analgesics are: Tramadol, Morphine, Fentanyl, Methadone

Mechanism of Action

Before we jump into the mechanism of action of opioid analgesics, let’s recall the steps of creation & propagation of pain in the body that we discussed here. There were 6 steps from release of prostaglandin to interpretation of pain in brain.
Non-opioid analgesics relieve pain by inhibiting prostaglandin release, while unlike NSAIDs, opioid analgesics do not primarily act on the peripheral system; instead, they block pain transmission in the spinal cord and brain, i.e. step 5 & 6.

Now, let’s discuss how pain travels in spinal cord and what are μ receptor

Let’s try to understand this image:
1) Here we have two neurons, one on the left and one on the right, and the pain signal is traveling from left to right.
2) Between these two neurons, there is a small space filled with chemical neurotransmitters such as Substance P and Glutamate, which transmit the pain signal.
3) This junction is called a synapse, and the space between the two neurons is known as the synaptic cleft.
4) Therefore, the left neuron is called the pre-synaptic neuron, and the right neuron is called the post-synaptic neuron.

Now let’s understand what is happening here

• In Presynaptic terminal, the electric signal of pain is converted to chemical signal and this is how it happens:
  Terminal membrane depolarizes -> Voltage gated calcium (Ca²⁺) channels opens -> calcium moves inside -> already stored Substance P & glutamate moves out as soon as Ca²⁺ ion moves in.

• In Postsynaptic terminal,
  Substance P -> bind to NK-1 receptors
  Glutamate → bind to AMPA / NMDA receptors
  which result in depolarization of neuron and hence firing (electric signal movement) of neuron

Till now, we have discussed in detail the propagation of pain from one neuron to another. Now, let us understand how opioid analgesics block pain transmission at both the chemical (presynaptic) and electrical (postsynaptic) levels.

Action of opioid analgesic on presynaptic terminal

In a normal scenario, voltage-gated calcium (Ca²⁺) channels open, allowing calcium ions to enter the presynaptic terminal, which triggers the release of Substance P and glutamate. However, when an opioid analgesic is present, it activates μ-opioid receptors located on the presynaptic terminal. As a result, voltage-gated Ca²⁺ channels remain closed, calcium ions do not enter the neuron, and Substance P and glutamate are not released. Thus, the chemical transmission of the pain signal is blocked.

Action of opioid analgesic on postsynaptic terminal

First, it is important to understand that for a neuron to transmit an electrical signal (neuron firing), the membrane potential must become less negative.

At the postsynaptic terminal, opioid analgesics prevent the neuron from becoming less negative, thereby blocking signal transmission. This occurs as follows:

1. Opioid analgesics bind to μ-opioid receptors present on the postsynaptic terminal.
2. Activation of μ-receptors leads to Gi-protein activation, which opens potassium (K⁺) channels
3. Potassium ions move out of the neuron, making the membrane more negative (hyperpolarization), and as a result, the neuron fails to fire an action potential

In this way, opioid analgesics exert a dual action: they block chemical neurotransmitter release at the presynaptic terminal and prevent electrical signal transmission at the postsynaptic neuron.

Furthermore, the role of opioid analgesics in managing chronic pain has been a topic of ongoing research.

A friend or a foe?

Opioid analgesics act as a true friend in pain management by providing powerful and effective relief from moderate to severe pain. They work centrally at both the spinal cord and brain levels to block pain transmission and reduce pain perception. This makes them especially valuable in conditions such as post-operative pain, cancer pain, trauma, and palliative care.

By interrupting pain signals at multiple levels, these analgesics not only reduce physical pain but also decrease the emotional distress associated with severe pain. When used appropriately under medical supervision, they significantly improve patient comfort, quality of life, and overall well-being. This highlights their importance as an essential tool in modern medicine.

Despite their strong analgesic benefits, these analgesics have a significant drawback—the potential to cause addiction. This occurs because opioids act on μ-opioid receptors not only in pain pathways but also in the brain’s reward system, particularly areas involved in pleasure and motivation.

Activation of these receptors increases dopamine release, producing feelings of euphoria and relaxation. With repeated use, the brain adapts to the presence of opioids, leading to tolerance, where higher doses are required to achieve the same effect. Over time, physical dependence develops, and sudden withdrawal results in unpleasant symptoms.

Because of their effectiveness, these analgesics remain a cornerstone in pain management strategies. However, their benefits must always be balanced against their risks.

Opioid analgesics are powerful medicines designed to relieve moderate to severe pain when used under proper medical supervision. Their misuse can lead to serious consequences, including addiction, overdose, and even death.

Repeated or unsupervised use can alter normal brain function, making it difficult for individuals to stop using these drugs. Therefore, opioids should never be used without a valid medical indication, should not be taken in higher doses or for longer durations than prescribed, and must never be shared with others.

As a society, it is our responsibility to promote awareness, follow medical advice strictly, safely store and dispose of opioid medications, and support individuals struggling with dependence. Responsible use ensures that opioid analgesics remain a valuable medical tool rather than a public health threat.

Summary

Opioid analgesics are potent pain-relieving drugs that act primarily on μ-opioid receptors in the central nervous system (CNS). Unlike non-opioid analgesics, which reduce pain by inhibiting prostaglandin synthesis at peripheral sites, opioid analgesics block pain transmission at the spinal cord and brain levels. They relieve pain by reducing pain perception and altering the emotional response associated with pain.

At the spinal cord level, opioids exert a dual mechanism of action. Presynaptically, they inhibit the opening of voltage-gated calcium channels, thereby preventing the release of pain-transmitting neurotransmitters such as Substance P and glutamate. Postsynaptically, opioids activate μ-receptors that open potassium channels, causing hyperpolarization of neurons and preventing action potential generation. This combined chemical and electrical blockade effectively suppresses pain signal transmission.

Clinically, these analgesics are highly effective in managing moderate to severe pain, particularly in conditions such as post-operative pain, cancer pain, trauma, and palliative care. However, their action on the brain’s reward system can lead to tolerance, physical dependence, and addiction with prolonged or inappropriate use. Therefore, while these analgesics remain an essential and valuable tool in pain management, their use must be carefully regulated, medically supervised, and socially responsible to prevent misuse and associated public health risks.

Final Verdict

Opioid analgesics relieve pain by blocking neurotransmitter release presynaptically and preventing neuronal firing postsynaptically, but their use must be carefully monitored due to the risk of addiction.